Since the CB1R is involved in many physiological and pathophysiological processes, it is an attractive target for drug discovery to manage pain, neurodegenerative disorders, obesity, and substance abuse. This evidence concerns the gene CNR1 and obesity due to melanocortin 4 receptor deficiency.